A Phase III Randomized Controlled Clinical Trial Of Carboplatin and Paclitaxel Alone or in Combination with Bevacizumab (NSC #704865, IND #7921) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Periton

Service: Trial Number:
826-08
Principal Investigator: Conducted at:
Long Beach Medical Center
Currently enrolling additional patients:
Yes
Age Range:
18 & older
Gender:
Female

One purpose of this study is to compare the combination of carboplatin, paclitaxel and bevacizumab to the standard combination of carboplatin and paclitaxel alone. A second purpose of this study is to determine if a second surgery to remove tumor followed by chemotherapy can increase the time that you remain disease free.